Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3040% below fair value

$2.86−0.14 (-4.67%)

Close on Nov 13, 2026Market cap $122.83MP/E –Yield –

Pulmonx EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Pulmonx's EPS for the twelve months ending Sep 30, 2026 was -$1.01. For fiscal 2025 it was -$1.33. The highest annual figure on record is -$1.33 in fiscal 2025.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$1.33	–
FY2024	Dec 31, 2024	-$1.44	–
FY2023	Dec 31, 2023	-$1.60	–
FY2022	Dec 31, 2022	-$1.59	–
FY2021	Dec 31, 2021	-$1.35	–
FY2020	Dec 31, 2020	-$3.16	–
FY2019	Dec 31, 2019	-$11.66	–
FY2018	Dec 31, 2018	-$11.03	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$0.19	–
Q2 FY2026	Jun 30, 2026	-$0.24	–
Q1 FY2026	Mar 31, 2026	-$0.33	–
Q4 FY2025	Dec 31, 2025	-$0.25	–
Q3 FY2025	Sep 30, 2025	-$0.34	–
Q2 FY2025	Jun 30, 2025	-$0.38	–
Q1 FY2025	Mar 31, 2025	-$0.36	–
Q4 FY2024	Dec 31, 2024	-$0.33	–
Q3 FY2024	Sep 30, 2024	-$0.36	–
Q2 FY2024	Jun 30, 2024	-$0.39	–
Q1 FY2024	Mar 31, 2024	-$0.36	–
Q4 FY2023	Dec 31, 2023	-$0.36	–
Q3 FY2023	Sep 30, 2023	-$0.39	–
Q2 FY2023	Jun 30, 2023	-$0.43	–
Q1 FY2023	Mar 31, 2023	-$0.42	–
Q4 FY2022	Dec 31, 2022	-$0.38	–
Q3 FY2022	Sep 30, 2022	-$0.38	–
Q2 FY2022	Jun 30, 2022	-$0.40	–
Q1 FY2022	Mar 31, 2022	-$0.43	–
Q4 FY2021	Dec 31, 2021	-$0.35	–
Q3 FY2021	Sep 30, 2021	-$0.28	–
Q2 FY2021	Jun 30, 2021	-$0.36	–
Q1 FY2021	Mar 31, 2021	-$0.35	–
Q4 FY2020	Dec 31, 2020	-$0.27	–
Q3 FY2020	Sep 30, 2020	-$1.37	–
Q2 FY2020	Jun 30, 2020	-$6.15	–
Q1 FY2020	Mar 31, 2020	-$3.76	–
Q4 FY2019	Dec 31, 2019	-$2.48	–
Q3 FY2019	Sep 30, 2019	-$2.41	–
Q2 FY2019	Jun 30, 2019	-$3.24	–
Q1 FY2019	Mar 31, 2019	-$3.61	–